Since 2004, epidemiologist Jennifer Havens has followed the simultaneous spread of opioid abuse and hepatitis C in Eastern Kentucky injection drug-using networks. Havens is expediting solutions to the opioid and hepatitis C crisis in Appalachia through evidence-based interventions and policy recommendations.
Researchers and clinicians from the University of Kentucky Markey Cancer Center, the University of Louisville Brown Cancer Center and collaborating cancer programs from across the Commonwealth attended this year’s Kentucky Lung Cancer Symposium at UK’s William T. Young Library on Oct. 15.
Dr. John Gurley, director of the Structural Heart Program at UK HealthCare's Gill Heart Institute discussed a new implantable device that may reduce the risk of strokes for atrial fibrillation patients in Sunday's Herald Leader.
A recent study led by University of Kentucky researchers illuminates a new way that tobacco smoke may promote the development of lung cancer: inhibiting a DNA repair process called nucleotide excision repair (NER).